Partners Behind an MS Drug Take Their Dispute to Court
Thursday, August 6, 2009 - 23:42
in Psychology & Sociology
Biogen says its partner, Elan, has violated their deal to share ownership of the drug Tysabri. Elan says it has not.
Updated by artificial intelligence Sat, 3 Jan 2026, 15:40:35 UTC Learn more
- Tell your friends
- Get science news via